Pfizer receives regulatory approvals to complete the acquisition of Seagen

Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution

Progenesis opens genetic laboratory in New Delhi and AI & Bioinformatics data centre in Chennai

Leading USA based genetic testing brand officially enters the Indian market

Zepbound is now available in US for adults living with obesity

Express Scripts to add Zepbound to National Preferred Formulary

Evonik launches Ecohance Soft Baobab oil for natural cosmetic formulations

High-quality baobab oil sourced in collaboration with UNCCD and the Great Green Wall Initiative

Ashland launches Perfectyl to rock skin perfection without injection

Multi-ethnic innovation helps all complexions appear clearer and more uniform

Merck to acquire Caraway Therapeutics

Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases

Fosun Pharma USA and Treehill Partners to invest in biopharma space

The newly established business will be looking for high-quality, mid- to late-stage assets, clinically focused on the United States market

Evive Biotech and Acrotech Biopharma receive FDA approval of Ryzneuta

Lupin receives approval from US FDA for Ganirelix Acetate Injection

The product will be manufactured at Lupin’s Nagpur facility in India

Pfizer and Astellas' XTANDI approved by USFDA in earlier prostate cancer treatment setting

XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy in nonmetastatic castration-sensitive prostate cancer